Robert Langer

Institute Professor and Professor of ChemE & BE
New IP

Department
Office of the Institute Professors
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Cell Separation, Sensors & Monitoring, Biomanufacturing, Tissue Engineering, Prostheses, Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture, Animal Models / Therapeutics: Nucleic Acids, Cell Based Therapy, Regenerative Medicine, Small Molecules, Proteins & Antibodies, Vaccines / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Biomaterials & Bioelectronics: Health Monitoring, Medical Device Coatings, Tissue Repair / Communication Systems: Wireless / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Agriculture & Food: Delivery, Nutrition / Electronics & Photonics: Semiconductors / Industrial Engineering & Automation: Robotics / Computer Science: Bioinformatics / Energy & Distribution: Electrochemical Devices / Diagnostics: Imaging Agents

Prolific, award-winning pioneer of new technologies known for revolutionary contributions to the fields of medicine and biotechnology.

Background and Experience

Dr. Langer is one of nine Institute Professors at MIT – the highest honor that can be awarded to a faculty member. He has written more than 1,570 articles and has over 1,400 issued and pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 400 pharmaceutical, chemical, biotechnology, and medical device companies. He is the most cited engineer in history and was named as one of the 25 most important individuals in biotechnology in the world by Forbes Magazine (1999) and Bio World (1990).

Dr. Langer is one of three living individuals to have received both the United States National Medal of Science (2006) and the United States National Medal of Technology and Innovation (2011). In 1998, he was recognized as “one of history’s most prolific inventors in medicine”, receiving the Lemelson-MIT prize – the world's largest prize for invention. He is the director of the word's largest biomedical engineering lab whose research focuses on the interface of biotechnology and materials science.

Dr. Langer received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.

You have to realize that failure is OK. If you want to change the world, you have to be prepared to fail. You put your head down and keep going. ”
Robert Langer

Awards and Honors

Dr. Langer has received over 220 major awards including:

  • 41 honorary doctorates
  • Charles Stark Draper Prize | 2002
  • Albany Medical Center Prize in Medicine and Biomedical Research | 2005
  • Induction into the National Inventors Hall of Fame (2006)
  • Queen Elizabeth Prize for Engineering | 2015
  • Balzan Prize for Biomaterials for Nanomedicine and Tissue Engineering | 2022

Technologies

Flower-Inspired System with Shape-Memory Torsion Springs

Technology / Case number: #20940J
Carlo Giovanni Traverso / Ester Caffarel Salvador / Robert Langer / Sahab Babaee / Simo Pajovic
Technology Areas: Biotechnology
Impact Areas: Healthy Living
License

Tissue Platform and Machine Learning Algorithm for Drug-Drug Transporter Interaction Discovery

Technology / Case number: #21883J
Carlo Giovanni Traverso / Yunhua Shi / Vance Soares / Daniel Reker / Robert Langer
Technology Areas: Biomaterials & Bioelectronics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Structure-Guided Chemical Modification of Guide RNA and its Applications

Technology / Case number: #19175V
Hao Yin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Derivation of Enteroendocrine Cells and Insulin Expressing Cells

Technology / Case number: #18445J
Jeffrey Karp / Xiaolei Yin / Robert Langer
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Crystalline and Amorphous Formulations Used to Deliver Anti-Fibrotic (and other) Compounds in Conjunction with Implanted Materials (Cells/Devices)

Technology / Case number: #18287J
Joshua Doloff / Shady Farah / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
License

User-Friendly and Easily-Accessible Synthetic Hydrogels for Biomaterials Application

Technology / Case number: #20694
Owen Fenton / Robert Langer / Jason Andresen / Marion Paolini
Technology Areas: Chemicals & Materials / Therapeutics
License

Thermo-Responsive, Inflammation-Targeting (TRIT) Hydrogel Formulations for Local Drug Delivery in Intestinal Inflammation

Technology / Case number: #19181J
Carlo Giovanni Traverso / Sufeng Zhang / Ashok Kakkar / Joshua Korzenik / Robert Langer
Technology Areas: Chemicals & Materials / Drug Delivery
Impact Areas: Healthy Living
License

Gastric Residence Electronics

Technology / Case number: #20092J
Carlo Giovanni Traverso / Yong Lin Kong / Robert Langer
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Communication Systems
Impact Areas: Healthy Living
License

Macro-Devices for Ultra-Long Residence and Large-Dose Drug Delivery in Stomach

Technology / Case number: #20938JQ
Carlo Giovanni Traverso / Robert Langer / Sahab Babaee / Simo Pajovic / Jiuyun Shi
Technology Areas: Biotechnology / Drug Delivery
License

Systems for Electrical Stimulation

Technology / Case number: #20707JQ
Carlo Giovanni Traverso / Alex Abramson / David Dellal / Robert Langer
Technology Areas: Biotechnology / Drug Delivery
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.